Latest News and Press Releases
Want to stay updated on the latest news?
-
HOUSTON, Oct. 08, 2020 (GLOBE NEWSWIRE) -- A FibroGenesis, principal desenvolvedora de soluções terapêuticas com base em fibroblastos para necessidades médicas não atendidas, tem o orgulho de...
-
ヒューストン発, Oct. 09, 2020 (GLOBE NEWSWIRE) -- 満たされていない医療ニーズに応える線維芽細胞ベースの治療ソリューションの大手開発企業FibroGenesisは、Global Smart Leaders誌の2020年最も革新的な企業 (Most Innovative Companies of 2020)...
-
HOUSTON, Oct. 08, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, the leading developer of fibroblast based therapeutic solutions for unmet medical needs, is proud to announce Global Smart Leaders Magazine...
-
HOUSTON, Aug. 13, 2020 (GLOBE NEWSWIRE) -- A FibroGenesis, uma empresa de estudos clínicos que desenvolve soluções terapêuticas baseadas em fibroblastos voltadas para necessidades médicas não...
-
ヒューストン発, Aug. 13, 2020 (GLOBE NEWSWIRE) -- 線維芽細胞ベースの治療ソリューションの開発により、満たされていない医療ニーズに応える臨床開発企業FibroGenesisは本日、COVID-19治療へのPneumoBlast™製品の使用を後押しする新たなデータを発表した。...
-
HOUSTON, Aug. 12, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, una empresa de etapa clínica que desarrolla soluciones terapéuticas basadas en fibroblastos para cubrir necesidades médicas sin tratamiento,...
-
HOUSTON, 13 août 2020 (GLOBE NEWSWIRE) -- FibroGenesis, une société de stade clinique qui développe des solutions thérapeutiques à base de fibroblaste pour les besoins médicaux non satisfaits,...
-
HOUSTON, Texas (USA), Aug. 13, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, ein Unternehmen im Bereich der klinischen Forschung, das therapeutische Lösungen auf Fibroblastenbasis für ungedeckte...
-
HOUSTON, Aug. 12, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, a clinical stage company developing fibroblast based therapeutic solutions for unmet medical needs, announced today new data supporting...